![Thomas Guiel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 9 306 $ as of 30/07/2026
Thomas G.
Guiel worked as Principal at Invitrogen Corp., Vice President-Operations at CapForce, Inc., Chief Operating Officer & Executive Vice President at OncoPlex Diagnostics, Inc. from 2013 to 2018, and Chief Operating Officer at Oxford BioDynamics Plc.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/11/2025 | 6,288,146 ( 0.15% ) | 9 306 $ | 30/07/2026 |
| Companies | Position | End |
|---|---|---|
OncoPlex Diagnostics, Inc.
 OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Chief Operating Officer | 31/12/2017 |
| OXFORD BIODYNAMICS PLC | Chief Operating Officer | - |
| CAPFORCE INC. | Chief Operating Officer | - |
Invitrogen Corp.
 Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
OpGen, Inc.
 OpGen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies against life-threatening, antibiotic-resistant infections using molecular diagnostics and bioinformatics | Commercial Services |
OncoPlex Diagnostics, Inc.
OncoPlex Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates a cancer diagnostics laboratory | Health Services |
Oxford BioDynamics Plc
 Oxford BioDynamics Plc BiotechnologyHealth Technology Discovers and develops novel biomarkers | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
